Results 41 to 50 of about 47,082 (157)

El negocio del VIH/SIDA: patentes farmacéuticas ¿para qué y para quién? [PDF]

, 2006
¿Para qué y para quién son las patentes farmacéuticas? Son algunas de las interrogantes que este libro responde tomando en cuenta el fortalecimiento de las patentes farmacéuticas en la OMC y sus impactos sobre el acceso a medicamentos para el VIH/ SIDA ...
Gallardo Fierro, Lucía
core   +1 more source

Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome–associated Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract INTRODUCTION This study investigates the evolution with disease progression and pathological correlates of peak width of skeletonized mean diffusivity (PSMD), a sensitive diffusion magnetic resonance imaging (MRI) marker of microvascular white matter (WM) injury, in sporadic Alzheimer's disease (sAD) and Down syndrome (DS)–associated AD (DSAD).
Alejandra O. Morcillo‐Nieto, Maria Franquesa‐Mullerat, Sara E. Zsadanyi, José Enrique Arriola‐Infante, Lídia Vaqué‐Alcázar, Mateus Rozalem‐Aranha, José Allende Parra, Zili Zhao, Javier Arranz, Íñigo Rodríguez‐Baz, Lucia Maure‐Blesa, Laura Videla, Isabel Barroeta, Laura Del Hoyo Soriano, Bessy Benejam, Susana Fernández, Aida Sanjuan Hernandez, Lucia Pertierra, Sandra Giménez, Miguel Santos‐Santos, Oriol Dols‐Icardo, Ignacio Illán‐Gala, Daniel Alcolea, Olivia Belbin, Alberto Lleó, María Carmona‐Iragui, Juan Fortea, Alexandre Bejanin   +27 more
wiley   +1 more source

OS MEDICAMENTOS E AS PATENTES PIPELINE: CONVERGÊNCIAS E DISTANCIAMENTOS ENTRE A ORDEM JURÍDICA CONSTITUIÇÃO BRASILEIRA E AS PREVISÕES ESTRANGEIRAS

Revista Direitos Humanos e Democracia, 2016
O presente trabalho visa aquilatar uma análise geral sobre o tema “patente” em especial a pipiline, bem como suas formas de concessão e os principais acontecimentos relacionados à evolução do tema em na ordem jurídica brasileira e no cenário estrangeiro.
Dirceu Pereira Siqueira, Bruna Fernandes Alves   +1 more
doaj   +1 more source

Mapping the Technological and Pharmacological Landscape of Casearia sylvestris: An Evidence‐Based Prospection for Wound Healing and Pain Management

Chemistry &Biodiversity, Volume 23, Issue 5, May 2026.
Technological prospection of Casearia sylvestris for wound healing reveals limited patent and scientific production, concentrated on topical formulations and associated analgesic and anti‐inflammatory properties. Key innovation gaps persist, including insufficient chemical and biological standardization, lack of clinical evidence, and restricted ...
Luiza Gonçalves Soutier, Yasmim Parisotto de Souza Silva, Carla Suelen Gurski, Jaqueline Carneiro, Jéssica Brandão Reolon, Roberto Pontarolo, Marcel Henrique Marcondes Sari, Gabriel Blum Vestena, Weber Cláudio Francisco Nunes da Silva, Juliana Sartori Bonini, Luana Mota Ferreira   +10 more
wiley   +1 more source

Monovalent mannose‐glycoconjugates of sulforaphane reprogram human dendritic cells via NFATc1 to induce immune tolerance under inflammatory conditions

British Journal of Pharmacology, Volume 183, Issue 9, Page 1993-2008, May 2026.
Abstract Background and Purpose Immune tolerance prevents inflammation and autoimmunity, with dendritic cells (DCs) playing a key role. Reprogramming DCs towards a tolerogenic state represents a promising therapeutic strategy. Sulforaphane (SFN) has known immunomodulatory effects, but its clinical application is limited by poor stability and ...
María Elena Angarita‐Planchez, Camila Leiva‐Castro, Ana M. Múnera‐Rodríguez, Macarena Martínez‐Bailén, Ana T. Carmona, Soledad López‐Enríquez, Francisca Palomares   +6 more
wiley   +1 more source

A Comprehensive Evaluation of Patient Satisfaction and Clinical Outcomes in Poly‐L‐Lactic Acid Treatments—A Randomized, Interventional, and Comparative Clinical Study

Journal of Cosmetic Dermatology, Volume 25, Issue 5, May 2026.
ABSTRACT Background Poly‐L‐lactic acid (PLLA) is widely used in aesthetic medicine due to its bio‐stimulatory properties. However, limited research has compared different PLLA formulations. Aim To evaluate the impact of PLLA formulation and injection depth (subcutaneous vs. supraperiosteal) using objective and subjective assessments.
Victor R. M. Munoz‐Lora, Danielle Dias, Fernanda Bezerra, Ana C. N. Carnevali, Rud Varela, Andrea D. Tedesco, Pietra Roschel, Gabriela Giro, Patrícia Pauletto, Victor Rogerio, Marcelo Germani   +10 more
wiley   +1 more source

Propiedad intelectual y patentes sobre usos medicinales en conocimientos tradicionales

Investigación Agraria, 2018
En este trabajo se analiza el conocimiento tradicional sobre las supuestas propiedades medicinales de plantas y sus usos, como parte de los bienes comunes, que tiene la protección del derecho interno y del derecho internacional. Se consideran los usos de
Ramón Fogel
doaj   +1 more source

Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome

Alzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION White matter hyperintensities (WMH) are common in Down syndrome (DS), yet their longitudinal evolution and associations with Alzheimer's disease (AD) remain unclear. METHODS Longitudinal MRI study, including 80 DS adults and 53 euploid controls. WMH were segmented on serial FLAIR using a longitudinal pipeline.
Alejandra O. Morcillo‐Nieto, Mateus Rozalem‐Aranha, Lucia Maure‐Blesa, Íñigo Rodríguez‐Baz, José Enrique Arriola‐Infante, Maria Franquesa‐Mullerat, Sara E. Zsadanyi, Lídia Vaqué‐Alcázar, José Allende Parra, Zili Zhao, Javier Arranz, Laura Videla, Isabel Barroeta, Laura Del Hoyo Soriano, Bessy Benejam, Susana Fernández, Aida Sanjuan Hernandez, Lucia Pertierra, Sandra Giménez, Daniel Alcolea, Olivia Belbin, Alberto Lleó, María Carmona‐Iragui, Juan Fortea, Alexandre Bejanin   +24 more
wiley   +1 more source

Los límites de las patentes farmacéuticas [PDF]

, 2008
I. Introducción. II. Antecedentes: la patentabilidad de los productos farmacéuticos. III. La excepción de uso experimental: la cláusula Bolar. IV. Las licencias obligatorias. V.
Pons de Vall, Marta
core   +2 more sources

Estratégia de proteção de patentes farmacêuticas: o caso do atazanavir

RECIIS, 2016
O alto custo dos medicamentos antirretrovirais (ARVs) justifica estudos sobre estratégias de patenteamento farmacêutico vis-à-vis à política pública brasileira de acesso universal aos ARVs.
Carla Cristina de Freitas da Silveira, Marilena Cordeiro Dias Villela Corrêa, Wanise Borges Gouvea Barroso   +2 more
doaj   +1 more source